TGA vs SUSMP: Australian Pharmacy Practices and Future Implications

This report provides an overview of pharmacy practices in Australia, focusing on the Therapeutic Goods Administration (TGA) and the SUSMP (Standard for the Uniform Scheduling of Medicines and Poisons). It discusses the current pharmacy practices in relation to TGA and SUSMP, highlighting their roles in regulating therapeutic goods and classifying poisons and drugs, respectively. The report compares and contrasts TGA and SUSMP, outlining their functions within the Australian healthcare system, including the control of import, supply, manufacture, and export of therapeutic goods. Furthermore, it examines the implications of integrating pharmacists into team care to enhance patient awareness, medication adherence, and self-management of chronic diseases. The conclusion emphasizes the integral role of pharmacists in maintaining the quality use of medicines and upholding the objectives of the National Medicine Policy, underscoring the importance of risk assessment and regulatory control in ensuring public well-being and safety.

Pharmacy in Australia Healthcare
Therapeutic Good Administration SUSMP
The Poisons Standard

Table of Content.
INTRODUCTION...........................................................................................................................1
Current pharmacy practices.........................................................................................................1
Similarities and differences..........................................................................................................1
Implications to future practice.....................................................................................................2
CONCLUSION................................................................................................................................2
REFERENCES................................................................................................................................3

INTRODUCTION
The poison standards are generally a legislative instruments for the purposes of the
legislation Act 2003. in this, the poison standards can involve the decisions corresponding to the
classifications of medications and poisons into a schedules for inclusion in the relevant
legislation of the states and territories. The construct of medicine regulations, drugs as well as
poison in the New South Wales (NSW) is generally set out in the poisons and a therapeutic good
act 1996 and its related regulations. Such legislations are designed to protect the welfare and
well-being of the members of the NSW community. The report will cover description about the
good therapeutic administration within Australia. In addition to this, it will also cover the
description about SUSMP The poison standards within Australia and how these can be applied
within the current pharmacy practices. The discussion will also include the effective implications
to TGA and SUSMP to the future pharmacy practices (Dorato, S., 2018).
Current pharmacy practices.
The Therapeutic Good administration can effectively regulates the therapeutic goods
through the pre-market categorization, the post market observation as well as implementation of
the effective standards. In addition to this, the licensing of the Australian manufacturers and
verifying the overseas manufacturer conformation with the similar regulation as their Australian
equivalent. The TGA can be applied to the current pharmacy practices such that it is mainly
responsible for regulating the therapeutic goods containing the prescription medications,
vitamins and minerals, vaccines, medical devices and many more. The SUSMP's can be applied
within pharmacy as its basic role is to classify the poisons and drugs into various different
schedules as well as can indicate the level of control that is suggested to be exercised over their
accessibility to the population (Byrne et. al., 2018).
Similarities and differences.
The therapeutic good administration is generally a component of the Australian
Government Department of health, that is mainly accountable for control the import, supply,
manufacture, export as well as promoting the effective therapeutic goods. This can involve such
as medical devices, medications, vaccines, the blood and its products, cell and tissue derived
products, in-vitro diagnostic tests and many more. In addition to this, it can involve a poison list
which is generally a list of substance to which the therapeutics good Act and poisons and the
1

regulations can apply. It specifically involve the very eight schedules and in which the schedule
one is empty. In this, the schedules are aligned more closely with the standards for the Uniform
scheduling of medicines and Poisons (GUIDE TO POISONS AND THERAPEUTIC GOODS
LEGISLATION FOR PHARMACISTS, 2015).
Implications to future practice.
In this, currently there is only one accepted practice level within Australia, still, the
healthcare professionals declare that some of the pharmacists are so practising at an advance
level. In addition to this, integrating the pharmacists in a team care can enhances the patient
awareness of the value of medication adherence and further supports and promote the behaviour
alterations and the self-management of various chronic disease. In addition to this, the
pharmacists can furnish the screening services and involve a high access to the community that is
accountable healthcare organization could advantage for their welfare (Phillips et. al., 2021).
CONCLUSION
From the above discussion, it is concluded that the pharmacists within Australia generally
play an integral role in maintaining the quality use of the medicines and can upholding the
objectives of the National Medicine policy. In this, it is analysed that the pharmacist involve
various opportunities in order to showcase their skills within community and the healthcare
settings. It is analysed from the above discussion that the Therapeutic goods administration can
approve as well as regulates the care products which are significantly based on the assessment of
risks against the welfare. It can involve potential risks in which some of them are quite major and
some of which are minor. It can apply the scientific as well as the clinical expertise towards its
decision making to assure the asset of a care product surpass the particular hazard. Furthermore,
the scheduling is generally a national classification system which can control the poisons and the
medications being made available to the population. These such are effectively classified into the
schedules as per the regulatory control levels over the availability of poison and medications
needed to protect the public well-being and its safety.
2

REFERENCES
Books and Journals:
Byrne, G.A., Wood, P.J. and Spark, M.J., 2018. Non-prescription supply of combination
analgesics containing codeine in community pharmacy: A simulated patient
study. Research in Social and Administrative Pharmacy, 14(1), pp.96-105.
Dorato, S., 2018. General concepts: Current legislation on cosmetics in various countries.
In Analysis of Cosmetic Products (pp. 3-37). Elsevier.
Phillips, G.A., Muppidi, S., Sahagian, G., Smith, G., Huang, D. and Campbell, D., 2021. PND10
Conceptualization and Novel Budget Impact Analysis Framework for Treatments of
Myasthenia Gravis. Value in Health, 24, pp.S159-S160.
Puthran, P., 2019. Developing an Automated Data Extraction Tool for Tobacco Control Policy
Surveillance at the Local Government Level (Doctoral dissertation, University of
California, Davis).
Online:
GUIDE TO POISONS AND THERAPEUTIC GOODS LEGISLATION FOR PHARMACISTS,
2015 [Online] Available through:
<https://www.health.nsw.gov.au/pharmaceutical/Documents/guide-pharmacists.pdf>
3